Clinical trials: Infection of Total Knee Joint Prosthesis, open to volunteers
Infection of Total Hip Joint Prosthesis, Infection of Total Knee Joint Prosthesis
Topical Vancomycin for Infection Prophylaxis in TJA
11% of the general population undergo total hip arthroplasty (THA) in their lifetime and 7% undergo total knee arthroplasty (TKA), with these rates expected to rise up to 50% by 2026.
- Trial name
- NCT04993027
- Testing
- Vancomycin Powder
- Volunteers
- 100 people
- Sponsor
- Alberta Hip and Knee Clinic
Arthroplasty, Arthroplasty Replacement, Knee
oneKNEE - Prospective, Non-interventional, Multicenter PMCF-Study
Safety and Clinical Performance in terms of clinical outcome of oneKNEE® (total knee arthroplasty TKA), evaluated 2 years after implantation.
- Conditions
- Arthroplasty, Arthroplasty Replacement, Knee, Prosthetic Joint Infections of Knee, TKA Outcomes
- Trial name
- oneKNEE (NCT07682909)
- Testing
- oneKNEE®
- Volunteers
- 1,020 people
- Sponsor
- Aesculap AG